Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07524907 · ClinicalTrials.gov registry record
Stunting and Targeting Reduction of Impaired Growth in Kids Effectively
A clinical trial, sponsored by Abbott Nutrition.
- Not yet
- Registry status
- 150
- Enrollment target
NCT07524907: Clinical Trial study, sponsored by Abbott Nutrition.
NCT07524907 is a clinical trial that has not yet begun recruiting, run by Abbott Nutrition. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07524907 has not yet begun recruiting, sponsored by Abbott Nutrition.
- NOT YET RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
The objective of this prospective, real-world evidence/pragmatic study with a quality improvement program approach is to evaluate the feasibility and effectiveness of a community-engaged nutrition-focused program utilizing nutrition screening, education, supplementation and continuous follow up for children and their families.
Primary Outcome
Caregiver and NGO staff program experience assessed via survey via Net Promoter Score (NPS) scored from 0 to 10 where higher score is more favorable
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-01 |
What is known before NCT07524907 opens enrollment
NCT07524907 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07524907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07524907 about?
NCT07524907 is a clinical study titled "Stunting and Targeting Reduction of Impaired Growth in Kids Effectively". The objective of this prospective, real-world evidence/pragmatic study with a quality improvement program approach is to evaluate the feasibility and effectiveness of a community-engaged nutrition-focused program utilizing nutrition screening, education, supplementation and continuous follow up for ...
What is the current status of trial NCT07524907?
This trial is currently not yet recruiting. The enrollment target is 150 participants. The study started on 2026-06. Estimated completion is 2028-01.
Who is sponsoring clinical trial NCT07524907?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia